$BXP 4/A SEC Filings

Filed On	Filing
27 Jan 2026	Form 4/A: Labelle Michael E, EVP and CFO Gave up 1,252 shares to cover exercise price or tax ($84K)
27 Jan 2026	Form 4/A: Spann Hilary J., Executive Vice President Gave up 1,002 shares to cover exercise price or tax ($67.2K)
27 Jan 2026	Form 4/A: Kevorkian Eric G, SVP, CLO and Secretary Gave up 97 shares to cover exercise price or tax ($6.51K)
01 Nov 2010	Form 4/A: Twardock David A, Director Granted 300.77 Phantom Stock Units ($25K)
23 Dec 2009	Form 4/A: Burt Frank D, Senior Vice President Exercised 1,500 LTIP Units ($375)
23 Dec 2009	Form 4/A: Pester Robert E, Senior Vice President Exercised 9,333 LTIP Units ($2.33K)
01 Dec 2009	Form 4/A: Johnston Peter D, Senior Vice President Received 200 shares by exercise or conversion ($6.52K) · Sold 200 shares ($13.4K)
02 Jan 2008	Form 4/A: Linde Edward H, Director Exercised 85,000 Stock Option (right to buy)
02 Jan 2008	Form 4/A: Linde Edward H, Director Exercised 50,000 Stock Option (right to buy)
18 Jan 2007	Form 4/A: Burt Frank D, Senior Vice President Received 2,000 shares by conversion · Sold 2,000 shares ($230K)
11 Aug 2005	Form 4/A: Linde Edward H, Director Received 20,000 shares by exercise or conversion ($688K) · Sold 20,000 shares ($1.4M) · Received 14,600 shares by exercise or conversion ($502K) · 1 more
30 Nov 2004	Form 4/A: Linde Edward H, Director Received 14,000 shares by exercise or conversion ($481K) · Sold 14,000 shares ($844K)
01 Oct 2003	Form 4/A: Twardock David A, Director Granted 4.81 Dividend Equivalent Rights
01 Oct 2003	Form 4/A: Turchin Martin, Director Granted 97.91 Dividend Equivalent Rights
01 Oct 2003	Form 4/A: Patricof Alan J, Director Granted 113.39 Dividend Equivalent Rights
01 Oct 2003	Form 4/A: Landis Alan B, Director Granted 82.21 Dividend Equivalent Rights
01 Oct 2003	Form 4/A: Daley William M, Director Granted 5.14 Dividend Equivalent Rights
01 Oct 2003	Form 4/A: Salomon Richard E, Director Granted 84.6 Dividend Equivalent Rights
01 Oct 2003	Form 4/A: Bacow Lawrence S, Director Granted 5.14 Dividend Equivalent Rights

Comments